跳至主要内容
临床试验/IRCT20160417027437N3
IRCT20160417027437N3尚未招募3 期

Investigating the effectiveness of zinc supplementation on the possibility of relapse of anxiety and depression in opioid dependent patients under methadone maintenance treatment.

Ahvaz University of Medical Sciences0 个研究点目标入组 76 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 months(—)
性别
All

入选标准

  • Age 18 to 60 years
  • Diagnosis of substance abuse disorder based on DSM-V diagnostic criteria
  • Receiving methadone as the only treatment protocol

排除标准

  • History of allergy to compounds containing zinc
  • The use of compounds containing zinc and other medicinal supplements before intervention and study
  • Having harmful thoughts to yourself and others

研究者

相似试验